• aids-vaccine
  • potential-of-aids-vaccine
  • IAVIs-integrated-approach
  • antibody-discoveries-propel-vaccine-design
  • working-to-ensure-future-access
  • aids-is-the-leading-killer-of-women
  • AIDS Vaccine

    Recent discoveries have given
    researchers new clues and new
    optimism in the quest for safe
    and effective AIDS vaccines.

    Learn More
  • The Potential of
    an AIDS Vaccine

    As researchers make significant
    progress toward the development of
    an AIDS vaccine, new modeling data
    highlights its potentially striking impact.

    Learn More
  • IAVI's Integrated
    Approach

    IAVI partners with more than
    50 academic, biotechnology,
    pharmaceutical and governmental
    institutions to develop AIDS
    vaccines, and to advocate for
    the HIV-prevention field.

    Learn More
  • Antibody Discoveries
    Propel AIDS Vaccine
    Design Efforts

    Scientists working in global partnership have isolated
    more than 20 broadly neutralizing antibodies to HIV in recent
    years, providing new targets for vaccinologists.

    Learn More
  • Working to Ensure
    Future Access

    IAVI is working with partners to
    ensure that once a preventive
    AIDS vaccine is developed,
    it will be available to those
    who need it most.

    Learn More
WAVD-message-video-image

Publications

Pages-from-IR Vol18No2 Cover-ContentPagesIAVI Report
The Journal of AIDS Vaccine Research

Making Antibodies in Bulk: At What Cost?

The potential success of broadly neutralizing monoclonal antibodies for HIV prevention, treatment, and possibly even a cure could come at a cost

Read more

cover art url
Not a Scientist? VAX is the bulletin on AIDS vaccine research for you.

AIDS Vaccine Basics

Subscribe

Subscribe to IAVI Report and VAX for free.